Should We Start Using OCT in Myocardial Infarction with Non-Obstructive Lesions?

In ST elevation MI, the common assessment methodology continues to the angiography; however, we all know it has certain limitations, especially when it comes to intermediate lesions or coronary dissections.  

¿Debemos comenzar a usar OCT en los IAM sin lesiones obstructivas?

Using imaging, especially high resolution such as OCT, has been looked into by some studies, but never randomized studies. 

The EROSION III is a randomized controlled study on patients with ST elevation MI who after guidewire lesion crossing should present a non-obstructive lesion (≤70%) and TIMI flow III. Predilation was excluded, but thrombus aspiration was allowed, when necessary. 

The study looked at 226 patients, 112 guided by OCT and 114 by angiography.

There were no differences between populations: mean age was 55, 80% were men, 21% were diabetic. Thrombus aspiration was done in 93% of patients and obstruction rate was 54%.

Read also: Is Increased Mitral Valve Gradient After MitraClip a Long-Term Prognostic Factor?

OCT patients saw 66% plaque rupture, 26% plaque erosion, 4.5% calcified nodules, 0.9% intimal fissure and 2.7% no evidence of obstruction or atherosclerotic lesion. 

Anterior descending infarction was more frequent in the OCT group. Also, this population presented longer procedural time.  

The OCT group saw 15% reduction in stent implantation (43.8% vs 53.8% p=0.024) and residual lesions (4.6% vs 8.7% p<0.001).

Read also: Hypertrophic Cardiomyopathy: Analyzing a Historical Series.

After one year, there were no differences in death, stroke, MI, TLR, malign arrythmia, rehospitalization for unstable angina or cardiac failure. 

Conclusion

In patients with ST elevation MI, OCT guided reperfusión compared against angiography guided reperfusión was associated with lower stent implantation rate at primary PCI. These favorable results indicate the value of OCT imaging guided reperfusión in patients with ST elevation MI. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board in SOLACI.org .

Original Title: EROSION III A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency.

Reference: Haibo Jia, et al. J Am Coll Cardiol Intv 2022;15:846–856.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....